Literature DB >> 10868946

Leptin induces direct vasodilation through distinct endothelial mechanisms.

G Lembo1, C Vecchione, L Fratta, G Marino, V Trimarco, G d'Amati, B Trimarco.   

Abstract

In this study, we reveal that leptin evokes an acute hypotensive effect in 6-hydroxydopamine sympathectomized rats (response to maximal leptin dose, mean blood pressure: from 92 +/- 4 to 78 +/- 2 mmHg, P < 0.01). This hemodynamic effect is related to a direct action of the hormone on vascular tone, since in aortic and mesenteric rings increasing doses of leptin evoke a dose-dependent vasorelaxation (aorta: from 3 +/- 1 to 36 +/- 3, n = 15; mesenteric: from 6 +/- 1 to 30 +/- 5, n = 10), which is impaired by endothelial denudation. In particular, leptin-evoked vasorelaxation is impaired by nitric oxide synthase inhibition in aorta (delta% of maximal response: from 36 +/- 3 to 3 +/- 1, P < 0.01) and by endothelium-derived hyperpolarizing factor (EDHF) inhibition in mesenteric arteries (delta% of maximal response: from 30 +/- 5 to 7 +/- 2, P < 0.01), suggesting that vasorelaxation evoked by leptin is heterogeneous and related to the vascular bed. Finally, the inhibition of nitric oxide synthase by NG-nitro-L-arginine-methyl ester does not modify blood pressure response to leptin, suggesting a predominant role of the EDHF mechanism in the hypotensive effect of leptin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868946     DOI: 10.2337/diabetes.49.2.293

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  78 in total

1.  Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia.

Authors:  Ronghua Yang; Gautam Sikka; Jill Larson; Vabren L Watts; Xiaolin Niu; Carla L Ellis; Karen L Miller; Andre Camara; Christian Reinke; Vladimir Savransky; Vsevolod Y Polotsky; Christopher P O'Donnell; Dan E Berkowitz; Lili A Barouch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

Review 2.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

Review 3.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 4.  Obesity, weight loss, and vascular function.

Authors:  Robert D Brook
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 5.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 6.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 7.  Mechanisms of adverse cardiometabolic consequences of obesity.

Authors:  Carlos M Diaz-Melean; Virend K Somers; Juan Pablo Rodriguez-Escudero; Prachi Singh; Ondrej Sochor; Ernesto Manuel Llano; Francisco Lopez-Jimenez
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 8.  Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

Authors:  Jarrod D Knudson; Gregory A Payne; Léna Borbouse; Johnathan D Tune
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

9.  Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model.

Authors:  Aaron K Bunker; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

Review 10.  Leptin: sympathetic and cardiovascular effects.

Authors:  Robert J Richards; Anthony Blalock; Jie Liao; Efrain Reisin
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.